Get started
ATAI Life Sciences N.V.ATAI Life Sciences N.V.ATAI Life Sciences N.V.

ATAI Life Sciences N.V.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

ATAI chart


Full chart

ATAI upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪556.09 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−149.27 M‬ USD
Revenue (FY)
‪308.00 K‬ USD
Shares float
‪137.08 M‬
Beta (1Y)
1.42

Employees


Employees (FY)
54
Change (1Y)
−29 −34.94%
Revenue / Employee (1Y)
‪5.70 K‬ USD
Net income / Employee (1Y)
‪−2.76 M‬ USD

About ATAI Life Sciences N.V.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Srinivas G. Rao
Website
atai.com
Headquarters
Berlin
Founded
2018
ISIN
NL0015000DX5
FIGI
BBG0107FR3K9
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Check out other big names from the same industry as ATAI.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ATAI news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ATAI is 2.63 USD — it has decreased by −0.72% in the past 24 hours. Watch ATAI Life Sciences N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ATAI Life Sciences N.V. stocks are traded under the ticker ATAI.
ATAI stock has risen by 23.87% compared to the previous week, the month change is a 7.84% rise, over the last year ATAI Life Sciences N.V. has showed a 102.31% increase.
We've gathered analysts' opinions on ATAI Life Sciences N.V. future price: according to them, ATAI price has a max estimate of 12.00 USD and a min estimate of 7.00 USD. Watch ATAI chart and read a more detailed ATAI Life Sciences N.V. stock forecast: see what analysts think of ATAI Life Sciences N.V. and suggest that you do with its stocks.
ATAI reached its all-time high on Jun 18, 2021 with the price of 22.91 USD, and its all-time low was 1.02 USD and was reached on Dec 1, 2023. View more price dynamics on ATAI chart.
See other stocks reaching their highest and lowest prices.
ATAI stock is 7.66% volatile and has beta coefficient of 1.42. Track ATAI Life Sciences N.V. stock price on the chart and check out the list of the most volatile stocks — is ATAI Life Sciences N.V. there?
Today ATAI Life Sciences N.V. has the market capitalization of ‪552.07 M‬, it has increased by 10.71% over the last week.
Yes, you can track ATAI Life Sciences N.V. financials in yearly and quarterly reports right on TradingView.
ATAI Life Sciences N.V. is going to release the next earnings report on Aug 18, 2025. Keep track of upcoming events with our Earnings Calendar.
ATAI earnings for the last quarter are −0.15 USD per share, whereas the estimation was −0.17 USD resulting in a 12.07% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about ATAI Life Sciences N.V. earnings.
ATAI Life Sciences N.V. revenue for the last quarter amounts to ‪1.55 M‬ USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ATAI net income for the last quarter is ‪−26.43 M‬ USD, while the quarter before that showed ‪−26.29 M‬ USD of net income which accounts for −0.55% change. Track more ATAI Life Sciences N.V. financial stats to get the full picture.
No, ATAI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 9, 2025, the company has 54 employees. See our rating of the largest employees — is ATAI Life Sciences N.V. on this list?
Like other stocks, ATAI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATAI Life Sciences N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ATAI Life Sciences N.V. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ATAI Life Sciences N.V. stock shows the buy signal. See more of ATAI Life Sciences N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.